baber/WOPTO huggingface dataset:
Patent NZ-270024-A (NZ)
Title: 2beta-(thio)morpholino substituted androstane and pregnane derivatives
Inventor: CAMPBELL ALEXANDER CUPPLES
IPC: C07J17/00
Filed: 1994-11-30
Abstract: The invention is related to substituted 2 beta -morpholino-androstane derivatives, bonded at their 2 beta -position to the nitrogen of a group of formula I   <IMAGE>   wherein R represents one to four substituents, each one independently selected from (1-4C) alkyl, phenyl and benzyl, or two at the same carbon atom being together -(CH2)n- wherein n is 2-6; and Y is O or S, or a pharmaceutically acceptable salt thereof. These steroids are very potent intravenous anaesthetics. The compounds have fast onset times and ideal 'sleep duration' vs. 'recovery to full coordination' profiles.
Patent NZ-301449-A (NZ)
Title: Ceramic tile manufacture from spent aluminum potlining
Inventor: HNAT JAMES G
IPC: C03C1/00
Filed: 1995-12-21
Abstract: The present invention relates to a process for forming glass-ceramic tiles. Spent aluminum potliner containing carbonaceous material, fluorine, and glass forming materials is oxidized under conditions effective to combust the carbonaceous material and volatilize partially the fluorine in the glass forming materials. The oxidized glass forming materials are vitrified to form a glass melt. This glass melt is then formed into tiles containing fluorine.
Patent NZ-312142-A (NZ)
Title: Therapeutic effervescent compositions
Inventor: MENTION JACKY ANDRE GUSTAVE
IPC: A61K9/46
Filed: 1996-06-28
Abstract: Granulates comprising an effervescent couple of anhydrous powdered monosodium citrate and powdered sodium bicarbonate and prepared using a roller compactor are formulated into pharmaceutical compositions.
Patent NZ-332114-A (NZ)
Title: A package assembly for keeping, storing, displaying and handling disc-shaped products
Inventor: LINDBLOM GORAN
IPC: B65D5/38
Filed: 1997-03-21
Abstract: PCT No. PCT/SE97/00489 Sec. 371 Date Mar. 15, 1999 Sec. 102(e) Date Mar. 15, 1999 PCT Filed Mar. 21, 1997 PCT Pub. No. WO97/38919 PCT Pub. Date Oct. 23, 1997A package assembly for keeping, storing, displaying and handling disc-shaped products, such as compact discs and the like, wherein the assembly is comprised of a sleeve or pocket that is produced by folding and/or gluing a first paperboard or cardboard-like blank, and a slide or tray which is intended to removably receive at least one disc-shaped product and which is produced by folding and/or gluing a second paperboard or cardboard-like blank, wherein the sleeve has an opening through which the product-carrying slide can be inserted and withdrawn, wherein the slide includes product-constraining means, and wherein the sleeve and the slide include mutually coacting means which function to maximize the extent to which the slide can be withdrawn from the sleeve for the removal and insertion of a product into the space intended therefor. According to the invention, a folded part of the slide in the region of its bottom part functions both as a part of a product-receiving pocket and as a partition wall that enables two products to be received in mutually parallel and mutually separated relationship, wherein the folded part includes a separate foldable flap that forms a bottom abutment for products received on respective sides of the partition wall, wherein the bottom abutment of said flap also functions to restrict the extend to which the slide can be withdrawn from the sleeve.
Patent NZ-334081-A (NZ)
Title: Pyrrolidine and piperidine derivatives as selective NMDA receptor subtype antagonists
Inventor: ALANINE ALEXANDER
IPC: A61K31/445
Filed: 1999-02-05
Abstract: Pyrrolidine and piperidine derivatives of the formula I, II, and III where: R1 and R2 are H, lower alkoxy, hydroxy, halogen, -CONH2 or -C(O)O-lower alkyl; or taken together are -O-CH2-O-; R3 and R4 are H, lower alkoxy, benzyloxy, halogen, hydroxy, -CONH2 or -SCH3 or taken together are -O-CH2-O; R5 is hydrogen or lower alkyl; X and Y are selected from -CH(OH)-, (CH2)n, -C(O)- or CH(lower alkoxy); m, n and p are 1 or 2. These compounds are used for treating diseases caused by the overactivation of NMDA receptor subtypes.
Patent NZ-334115-A (NZ)
Title: Subunit respiratory syncytial virus vaccine preparation
Inventor: CATES GEORGE A
IPC: G01N33/569
Filed: 1997-07-11
Abstract: A composition consisting of purified fusion (F) protein, purified attachment (G) protein and purified matrix (M) protein of respiratory syncytial virus (RSV) and a procedure for the coisolation and copurification of these proteins. This composition is used for immunising patients to induce an immune response by producing specific F, G and M antibodies against respiratory syncytial virus.
Patent NZ-501241-A (NZ)
Title: Fungicidal mixtures comprising a carbamate and an oxime ether carboxamide
Inventor: BIRNER ERICH
IPC: H04W16/00
Filed: 1998-05-18
Abstract: A fungicidal composition comprising synergistically effective amounts of a carbamate of formula I, wherein X is CH, n is 0, 1 or 2 and Y is halogen, alkyl or haloalkyl, and an oxime ether carboxamide of formula II, wherein R represents hydrogen or halogen.
Patent NZ-508549-A (NZ)
Title: A box for storing a storage medium having studs and cavities arranged in respective linear rows forming a uniform modular spacing of the studs and cavities
Inventor: KALCHER CONNY
IPC: G11B33/04
Filed: 1999-05-27
Abstract: A box for storing a storage medium, comprising two parallel walls. A first one of the walls has an outer surface 12 with protruding studs 14, and a second wall has an outer surface with cavities for receiving the studs 14 on another similar box. The studs 14 and cavities are provided in respective rows allowing two or more boxes to be stacked either aligned or shifted, and a row of several boxes shifted relative to each other is self supported and can stand on a tabletop without any support.
Patent NZ-508914-A (NZ)
Title: Device for mounting an internal clamp in a pipe which is not man-sized
Inventor: HECHT REINHARD
IPC: E03F3/06
Filed: 1999-08-04
Abstract: The installation of support rings within large diameter pipes  or  ducts (14) is made using a robotic  vehicle  (18) that  is  supported  on  wheels (20).  The  vehicle  tows  a carriage  (12) that latches with a coupling (28). The  rings are  located  in  sequence on the carriage and  are  handled automatically and placed into position.
Patent NZ-509378-A (NZ)
Title: Amorphous ammonium salts of eprosartan and pharmaceuticals thereof, useful for blocking angiotensin II receptors and useful for treating hypertension, congestive heart disease and renal failure
Inventor: VENKATESH GOPADI
IPC: A61K9/26
Filed: 1999-07-20
Abstract: Bioenhanced formulations comprising eprosartan or eprosartan mesylate in the amorphous ammonium salt form, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II (AII) receptors and to treat hypertension, congestive heart failure and renal failure are disclosed.
Patent NZ-510681-A (NZ)
Title: The use of colostrinin or the nonapeptide in a medicament as in a dietary supplement and in a pharmaceutical composition
Inventor: JANUSZ MARIN
IPC: A61K35/20
Filed: 1997-10-03
Abstract: A pharmaceutical comprises colostrinin in a form suitable for absorption through the mucosa of the oral/nasopharyngeal cavity and/or in a form suitable for absorption in the alimentary canal. Colostrinin is useful for the treatment of chronic disorders of the central nervous system, neurological disorders, mental disorders, dementia, neurodegenerative diseases, Alzheimer's disease, motor neurone disease, psychosis, neurosis, chronic disorders of the immune system, bacterial and viral aetiology in acquired immunological deficiencies, chronic bacterial and viral infections. Colostrinin may also be used as a dietary supplement for babies, small children and adults who have been subjected to chemotherapy, or who have suffered from cahexia or weight loss due to chronic disease. Also described is a pharmaceutical composition comprising the nonapeptide with the sequence Val-Glu-Ser-Tyr-Val-Pro-Leu-Phe-Pro (VESYVPLFP), which is useful for treating chronic disorders of the central nervous system or the immune system or Alzheimer's disease.
Patent NZ-512522-A (NZ)
Title: Method and use of a material for packing a nicotine-containing product
Inventor: KARLSSON ANDERS H F
IPC: B65D65/02
Filed: 2000-01-12
Abstract: A method of packaging a nicotine-containing product comprising placing the product in a package made of a known packaging material, wherein the material is a polymer based on dimethyl-2,6-naphthalene dicarboxynate and/or 2,6-naphthalene dicarboxylic acid monomers.
Patent NZ-513502-A (NZ)
Title: A method for introducing a nucleic acid into a mammalian neural stem cell or progenitor cell via the inherent transport mechanism of the cell
Inventor: ERIKSSON PETER
IPC: C12N15/87
Filed: 2000-01-14
Abstract: A  method  for  introducing a substance  comprising  a nucleic   acid  into  a  mammalian  neural  stem   cell   or progenitor   cell,   wherein  the  nucleic   acid   directly interacts  with the cell membrane of the cell or a component within  the  cell  membrane in vitro whereby  the  substance comprising the nucleic acid is taken up by the cell via  the inherent  transport  mechanism of the  cell,  is  disclosed. Also different applications of said method are disclosed.
Patent NZ-521151-A (NZ)
Title: Truncated mature myostatin proteins and Piedmontese alleles and uses thereof in promoting muscle growth
Inventor: KAMBADUR RAVI
IPC: C12N15/85
Filed: 2001-02-22
Abstract: Disclosed are polypeptides capable of promoting muscle growth comprising the mature myostatin peptide (amino acids 267-375 of SEQ ID NO: 1) truncated at or between amino acid positions 330-350. In particular, polypeptides of the invention are preferably truncated at 330 or 350 and are useful in the treatment of muscle wasting conditions, increasing the muscle mass of a non-human animals and other such uses. Alternatively, mature myostatin proteins having a mutation at position 314 (e.g. the Piedmontese allele ) also having the ability to promote muscle growth, and methods and uses involving these proteins are disclosed. Also disclosed are nucleic acids encoding such proteins and compositions comprising them. (62) Divided out of 502389
Patent NZ-525423-A (NZ)
Title: A head lice formulation
Inventor: MUNRO DEBORAH
IPC: A61Q5/02
Filed: 2001-09-19
Abstract: A lice and or a headlice treating composition which comprises adhatoda (5-30%) and stemona (5-30%). The composition may also contain the following purpurea, tea tree oil and sesame oil. A method for treating lice is also disclosed.
Patent NZ-526277-A (NZ)
Title: Adjustable profiling head for a wood cutting apparatus with control plates used for radial dimension variation
Inventor: STAGER BRADLEY R
IPC: B27G13/00
Filed: 2003-02-19
Abstract: In order to adjust a radial dimensions of a cutting apparatus a set of control plates 22 is located between clamping mechanisms for knives 11 and an adjacent body portion 12a, 12b so as bolts 32 can pass through the control plates 22. (62) Divided out of 524315
Patent NZ-527910-A (NZ)
Title: Enhancement of pre-attentive display warning by focal plane flashing of images
Inventor: ENGEL GABRIEL DAMON
IPC: H04N13/04
Filed: 2003-08-28
Abstract: A method of viewing displayed information by a user comprises a visual display system including at least two focal planes and a control system. The method is characterised by the following: - a) Displaying primary information in a distinct colour or pattern on a first focal plane. b) Displaying secondary information in a distinct colour or pattern, on at least, a second plane, and c) when primary and secondary information overlaps denoting an alarm situation, the displayed information will change colour or pattern to make the viewer aware of the situation.
Patent NZ-528036-A (NZ)
Title: Player information delivery
Inventor: BENNETT NICHOLAS LUKE
IPC: A63F13/00
Filed: 1999-11-26
Abstract: A gaming console having a display means and game control means arranged to control images displayed on the display means. The game control is arranged to display a base game wherein one or more random events are caused to be displayed and if a predefined winning event or combination of events result, a prize is awarded. The console is characterised in that a bonus trigger is provided whereby, when a bonus trigger event occurs a bonus feature is awarded. This bonus trigger event is independent of the base game and randomly generated to occur on average at a rate that is a predetermined hit rate of the feature.
Patent NZ-530680-A (NZ)
Title: A method and device for separating particulate material
Inventor: METCALFE GUY PARKER
IPC: B07C99/00
Filed: 2002-08-01
Abstract: A method of separating particulate material of differing size or density including the steps of: tumbling the particulate material to produce continuous or discrete avalanches in the surface of the particulate material to move particles of smaller size or higher density towards the centre of the particulate material and particles of larger size (16) or lower density radially outward from the centre of the particulate material; and extracting particles at selected radial locations (8, 10). A device for separating particulate material of differing size or density is also provided.
Patent NZ-531316-A (NZ)
Title: Method and composition for the triggered release of polymer-degrading agents for oil field use
Inventor: FREEMAN MICHAEL A
IPC: C09K8/66
Filed: 2000-11-13
Abstract: Disclosed herein are methods and related compositions for altering the physical and chemical properties of a substrate used in hydrocarbon exploitation, such as in downhole drilling operations. In a preferred embodiment a method involves formulating a fluid, tailored to the specific drilling conditions, that contains one or more inactivated enzymes. Preferably the enzyme is inactivated by encapsulation in a pH responsive material. After the fluid has been introduced into the well bore, one or more triggering signals, such as a change in pH, is applied to the fluid that will activate or reactivate the inactivate enzyme, preferably by causing it to be released by the encapsulation material. The reactivated enzyme is capable of selectively acting upon a substrate located downhole to bring about the desired change in the chemical or physical properties of the substrate.
Patent NZ-534025-A (NZ)
Title: Holding device for the protecting cage of an outboard engine
Inventor: KLIEWE GUNTER
IPC: B63H20/00
Filed: 2003-01-14
Abstract: Disclosed is a holding device for fixing a protecting cage to the shaft of the outboard engine of a boat, comprising a ring element (5) which is placed around the shaft (1) of the outboard engine and is detachably fixed thereto by at least one closure. The cross section of the ring element has the shape of a U profile, the opening of which faces the center of the ring element. The holding device also comprises at least one projecting part which is radially directed towards the outside at the upper end of the protecting cage (13) and is inserted into the opening of the U profile of the ring element, whereby the protecting cage can be mounted and dismounted in an easy and fast manner.
Patent NZ-535823-A (NZ)
Title: Imidazolin-2-ylmethyl substituted aralkylsulfonamides
Inventor: DILLON MICHAEL PATRICK
IPC: A61K31/4164
Filed: 2003-04-15
Abstract: Imidazolin-2-ylmethyl substituted arylalkylsulfonamide derivatives of formula (I), compositions comprising the same, methods for use, and methods of preparation thereof are disclosed, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-543970-A (NZ)
Title: Methods and compositions for interferon therapy
Inventor: ENGLER HEIDRUN
IPC: C12N15/87
Filed: 2004-06-04
Abstract: Disclosed is the use, in the manufacture of a medicament for treating BCG-resistant superficial bladder cancer in a human subject, of: i) a lyophilized composition comprising, in a citrate buffer system providing a pH of about 5 to about 6, HPbetaCD and a compound of formula I; ii) a recombinant adenoviral gene delivery system of serotype 2 having a deletion of the protein IX gene and containing a gene for a human a2b-interferon operably linked to a genetic regulatory element which modulates expression of the gene.
Patent NZ-546200-A (NZ)
Title: Document verification system
Inventor: SCOTT STEPHEN
IPC: G06F21/00
Filed: 2004-08-27
Abstract: A method and system are provided to enable a user to effect an action with respect to records for an identification document. The system comprises a network within which the user is able to establish a communications link, a calling line identification means for identifying the telephone number with which the communications link has been established, and a verification server connected to the network for verifying that the telephone number with which the communications link has been established corresponds with a telephone number associated with the document. When the calling line identification means receives the calling number from the user, it provides the user with a temporary code. The initial call placed by the user is then disconnected and the system places a call to the telephone number provided by the user and requests the temporary code from the user. The system enables the user to effect an action with respect to records pertaining to the document only upon successful verification that a telephone number associated with the document corresponds with the telephone number identified by the calling line identification means as the number with which the communications link was established and upon receipt of the correct temporary code from the user.
Patent NZ-550172-A (NZ)
Title: Post system for a railing wher the post is held from below the post base by fasteners engaging the post
Inventor: WALKER SIMON
IPC: E04H17/22
Filed: 2005-03-30
Abstract: A post system for a railing is disclosed. The post system includes a railing post (22), an insert (27) and a post base (30). The railing post has an elongated tubular body with first (26) and second ends. The insert is inserted snugly within the first end of the railing post. The post base is connectable to the first end of the railing post and may have an inner member and an outer member substantially encasing the inner member. The base has top and bottom surfaces, the top surface engaging the post. The bottom surface has a central recess in which apertures allow fasteners (47) to connect the post and the base.
Patent NZ-551629-A (NZ)
Title: Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides
Inventor: MAIENFISCH PETER
IPC: A01N43/40
Filed: 2005-06-22
Abstract: Disclosed is a method of combating and controlling insects or acarines which comprises applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest an insecticidally or acaricidally effective amount of a compound of formula (I) or a salt or oxide thereof wherein the ring TZZ' is a benzene, pyridine, pyrimidine, pyrazine, pyridazine, triazine, pyrrole, imidazole, quinoline, isoquinoline, thiophene, pyrazole, oxazole, thiazole, isoxazole, isothiazole, [1,2,3]triazole, [1,2,3]oxadiazole or [1,2,3]thiadiazole ring.
Patent NZ-555474-A (NZ)
Title: 4-(4-(imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
Inventor: ANDREWS DAVID
IPC: A61K31/4178
Filed: 2005-12-15
Abstract: Disclosed is a 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino)benzamide of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 is H or F, R2 is Cl, F, or CH3 and is ortho to the amide group, p is 0 or 1, R20 is CH3, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the above compound for treating cancer, fibroproliferative disorders, differentiative disorders, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, haemangioma, acute or chronic nephropathies, atheroma, atherosclerosis, arterial restenosis, autoimmune diseases, acute or chronic inflammation, bone diseases, or ocular diseases with retinal vessel proliferation.
Patent NZ-562943-A (NZ)
Title: Glucagon-like-peptide-2 (glp-2) analogues
Inventor: LARSEN BJARNE DUE
IPC: A61K38/26
Filed: 2006-05-04
Abstract: Provided is a glucagon-like peptide 2 (GLP-2) analogue or a pharmaceutically acceptable salt thereof, wherein said analogue comprises an amino acid sequence represented by the general formula: R 1-Z1-His-Gly-X3-Gly-X5-Phe-X7 -Ser-Glu-X10-X11-Thr-lle-Leu-Asp-X16-Leu-Ala-AlaArg- Asp-Phe-lIe-X24-Trp-Leu-lIe-X28-Thr-Lys-X31-X32-X33-Z2 _R2 wherein: R1 is hydrogen, C1-4 alkyl, acetyl, formyl, benzoyl or trifluoroacetyl X3 is Glu or Asp X5 is Ser or Thr X7 is Ser or Thr X10 is Met, Leu, Nle, or an oxidatively stable Met-replacement amino acid X11 is Asn, Ala, Lys or Ser X16 is Asn or Ala X24 is Asn or Ala X28 is Gin or Ala X31 is lie or deleted X32 is Thr or deleted X33 is Asp or deleted R2 is NH2 or OH; and Z1 and Z2 are independently absent or a peptide sequence of 3-20 amino acid units selected from the group consisting of Ala, Leu, Ser, Thr, Tyr, Asn, Gin, Asp, Glu, Lys, Arg, His, Met and Om; subject to the proviso that said analogue is other than: R1-Z1-His-Gly-X3-Gly-X5-Phe-X7-X8-Glu-X10-X11-Thr-Ile-Leu-Asp-Ala-Leu-Ala-AlaArg- Asp-Phe-lIe-X24-Trp-Leu-lIe-Ala-Thr-Lys-X31-X32-X33-Z2-R2; or R1-Z1-His-Gly-X3-Gly-X5-Phe-X7-X8-Glu-Leu-X11-Thr-lle-Leu-Asp-X16-Leu-Ala-AlaArg- Asp-Phe-lle-Ala-Trp-Leu-lIe-X28-Thr-Lys-X31-X32-X33-Z2-R2; wherein X8 is Asp or Ser, and wherein R1, Z1, R2, Z2, X3, X5, X7, X8, X10, X11, X16, X24, X28, X31, X32, and X33 are as defined herein. Further provided is the use of the compounds as a medicament.
Patent NZ-564254-A (NZ)
Title: Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
Inventor: FARINA MARCO
IPC: A61K31/454
Filed: 2006-05-17
Abstract: Disclosed herein are substituted oxadiazolone compounds of formula (I-b), wherein the substituents are as defined within the specification, as positive allosteric modulators of metabotropic receptors - subtype 5 ('mGluR5') which are useful for the treatment or prevention of central nervous system disorders such as for example, cognitive decline, both positive and negative symptoms in schizophrenia as well as other central or peripheral nervous system disorders in which the mGluR5 subtype of glutamate metabotropic receptor is involved. The invention is also directed to pharmaceutical compounds and compositions in the prevention or treatment of such diseases in which mGluR5 is involved.
Patent NZ-569042-A (NZ)
Title: Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epileptogenesis
Inventor: SMITH-SWINTOSKY VIRGINIA L
IPC: A61K31/353
Filed: 2006-12-19
Abstract: Disclosed is the use of a benzo-fused heterocycle sulfamide of formula (I), wherein the substituents are as defined in the specification, and their use in treating, preventing, arresting, inhibiting or reversing epileptogenesis.